MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000552572

Медицинская библиотека · Case reports in dermatology · 2026

Six Cases of Pemphigoid Nodularis during Treatment with Dipeptidyl Peptidase-4 Inhibitors.

Norikawa Natsumi, Kusano Misaki, Honda Aki, Yamamoto Toshiyuki

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

We investigated 6 cases of pemphigoid nodularis under treatment with dipeptidyl peptidase-4 (DPP-4) inhibitors.

CASE REPRESENTATION: In 3 cases, only nodules were observed at the initial presentation, but bullous lesions appeared during the course of the disease. All patients had diabetes mellitus and were taking DPP-4 inhibitors from 1 to 1.5 years. Anti-BP180Nc16a antibodies were positive in 3 cases, and low or negative in 3 cases. Full-length BP180 antibodies were analyzed in 2 of the 6 cases and were positive in both. Since patients with diabetes mellitus occasionally develop prurigo nodularis, it is important not to misdiagnose pemphigoid nodularis as prurigo nodularis.

CONCLUSION

There are few reports of pemphigoid nodularis under DPP-4 inhibitors. It should be noted that not only bullous pemphigoid but also pemphigoid nodularis can be induced by DPP-4 inhibitors.

Для цитирования: Norikawa Natsumi, Kusano Misaki, Honda Aki, Yamamoto Toshiyuki. Six Cases of Pemphigoid Nodularis during Treatment with Dipeptidyl Peptidase-4 Inhibitors.. Case reports in dermatology. 2026. DOI: 10.1159/000552572.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.